Neoadjuvant or adjuvant therapy for resectable gastric cancer: A systematic review and practice guideline for North America

Gastric Cancer

Volumn 16, Issue 1, 2013, Pages 28-40

  Knight, Greg ^a   Earle, Craig C ^b   Cosby, Roxanne ^c   Coburn, Natalie ^b   Youssef, Youssef ^d   Malthaner, Richard ^e   Wong, Rebecca K S ^f  

^a Grand River Regional Cancer Centre   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d Durham Regional Cancer Centre   (Canada)

^e LONDON HEALTH SCIENCES CENTRE   (Canada)

^f PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Adjuvant therapy; Clinical practice guideline; Gastric cancer; Neoadjuvant therapy; Systematic review

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN;

ADVANCED CANCER; ALOPECIA; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL PRACTICE; DIARRHEA; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRANULOCYTOPENIA; HEALTH CARE QUALITY; HUMAN; LEUKOPENIA; LOWER ESOPHAGUS SPHINCTER; LYMPHOCYTOPENIA; MUCOSA INFLAMMATION; NAUSEA; NEUROTOXICITY; NEUTROPENIA; NORTH AMERICA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; STOMACH CANCER; STOMATITIS; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; VOMITING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CANADA; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; HUMANS; NEOADJUVANT THERAPY; PRACTICE GUIDELINES AS TOPIC; STOMACH NEOPLASMS; SURVIVAL RATE; UNITED STATES;

EID: 84872680407     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-012-0148-3     Document Type: Article

References (62)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49(1):33-64. (Pubitemid 29094960)
2. Canadian Cancer Society's Steering Committee. Canadian Cancer Statistics 2009. Toronto: Canadian Cancer Society; 2009.
3. Middleton G, Cunningham D. Current options in the management of gastrointestinal cancer. Ann Oncol. 1995;6(Suppl 1):S17-26.
4. Hermans J, Bonenkamp JJ, Boon MC, Bunt AMG, Ohyama S, Sasako M, et al. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol. 1993;11(8):1441-7. (Pubitemid 23228247)
5. Earle CC, Maroun JA. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer. 1999;35(7):1059-64. (Pubitemid 29339187)
6. Mari E, Floriani I, Tinazzi A, Buda A, Belfiglio M, Valentini M, et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol. 2000;11(7):837-43.
7. Browman GP, Levine MN, Mohide EA, Hayward RSA, Pritchard KI, Gafni A, et al. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol. 1995;13(2):502-12.
8. Shea BJ, Bouter LM, Peterson J, Boers M, Andersson N, Ortiz Z, et al. External validation of a measurement tool to assess systematic reviews (AMSTAR). PLoS ONE. 2007;2(12):e1350. http://www.plosone.org/article/info:doi/10.1371/ journal.pone.0001350.
9. Oba K, Morita S, Tsuburaya A, Kodera Y, Kobayashi M, Sakamoto J. Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials in Japan. J Chemother. 2006;18(3):311-7.
10. Sakamoto J, Morita S, Tsuburaya A, Kodera Y, Matsui T, Kobayashi O, et al. Efficacy of adjuvant chemotherapy with oral fluorinated pyrimidines for patients with curatively resected gastric cancer. A meta-analysis of centrally randomized clinical trials. J Clin Oncol. 2005;23(16 Suppl):4022.
11. Sakamoto J, Tsuburaya A, Morita S, Matsui T, Oba K, Kodera Y, et al. Adjuvant chemotherapy with tegafur/uracil (UFT) for gastric cancer. A meta-analysis of centrally randomized clinical trials. J Clin Oncol. 2006;24(18 Suppl):4033.
12. Bajetta E, Buzzoni R, Mariani L, Beretta E, Bozzetti F, Bordogna G, et al. Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Ann Oncol. 2002;13(2):299-307. (Pubitemid 34704984)
13. Nashimoto A, Nakajima T, Furukawa H, Kitamura M, Kinoshita T, Yamamura Y, et al. Randomized trial of adjuvant chemotherapy with mitomycin, fluorouracil, and cytosine arabinoside followed by oral fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. J Clin Oncol. 2003;21(12):2282-7. (Pubitemid 46621864)
14. Chipponi J, Huguier M, Pezet D, Basso N, Hay J-M, Quandalle P, et al. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. Am J Surg. 2004;187(3):440-5. (Pubitemid 38299517)
15. Popiela T, Kulig J, Czupryna A, Szczepanik AM, Zembala M. Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer. Gastric Cancer. 2004;7(4):240-5.
16. Bouche O, Ychou M, Burtin P, Bedenne L, Ducreux M, Lebreton G, et al. Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann Oncol. 2005;16(9):1488-97. (Pubitemid 41226403)
17. Nitti D, Wils J, Dos Santos JG, Fountzilas G, Conte PF, Sava C, et al. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. Ann Oncol. 2006;17(2):262-9. (Pubitemid 43160116)
18. De Vita F, Giuliani F, Orditura M, Maiello E, Galizia G, Di Martino N, et al. Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study). Ann Oncol. 2007;18(8):1354-8. (Pubitemid 47305009)
19. Nakajima T, Kinoshita T, Nashimoto A, Sairenji M, Yamaguchi T, Sakamoto J, et al. Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Br J Surg. 2007;94(12):1468-76. (Pubitemid 350275624)
20. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810-20 (Erratum published in N Engl J Med. 2008 May 1;358(18):1977). (Pubitemid 350044801)
21. Di Costanzo F, Gasperoni S, Manzione L, Bisagni G, Labianca R, Bravi S, et al. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. J Natl Cancer Inst. 2008;100(6):388-98. (Pubitemid 351480516)
22. Kulig J, Kolodziejczyk P, Sierzega M, Bobrzynski L, Jedys J, Popiela T, et al. Adjuvant chemotherapy with etoposide, adriamycin and cisplatin compared with surgery alone in the treatment of gastric cancer: a phase III randomized, multicenter, clinical trial. Oncology. 2010;78:54-61.
23. Chang HM, Jung KH, Kim TY, Kim WS, Yang HK, Lee KU, et al. A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer. Ann Oncol. 2002;13(11):1779-85. (Pubitemid 35439458)
24. Karacetin D, Incekara O. A randomized trial of 5-fluorouracil, leucovorin, cisplatin and epirubicin (PELF) versus 5-fluorouracil, leucovorin and etoposide (ELF) given as adjuvant chemotherapy to patients with resected advanced gastric adenocarcinomas. J BUON. 2004;9(3):263-7. (Pubitemid 40360801)
25. Cascinu S, Labianca R, Barone C, Santoro A, Carnaghi C, Cassano A, et al. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial. J Natl Cancer Inst. 2007;99(8):601-7. (Pubitemid 47073541)
26. Di Bartolomeo M, Buzzoni R, Mariani L, Ferrario E, Katia D, Gevorgyan A, et al. Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma: a randomized phase III trial. Oncology. 2007;71(5-6):341-6. (Pubitemid 47573695)
27. Chang H, Kang Y, Min Y, Zang D, Kim G, Yang D, et al. A randomized phase III trial comparing mitomycin-C plus short-term doxifluridine (Mf) versus mitomycin-C plus long-term doxifluridine plus cisplatin (MFP) after curative resection of advanced gastric cancer (AMC 0201) (NCT00296335). J Clin Oncol. 2008;26(15 Suppl):4531.
28. Bamias A, Karina M, Papkostas P, Kostopoulos I, Bobos M, Vourli G, et al. A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. Cancer Chemother Pharmacol. 2010;65:1009-21.
29. Hartgrink HH, van de Velde CJH, Putter H, Songun I, Tesselaar MET, Kranenbarg EK, et al. Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol. 2004;30(6):643-9. (Pubitemid 39060735)
30. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11-20.
31. Boige V, Pignon J, Saint-Aubert B, Lasser P, Conroy T, Bouche O, et al. Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703. J Clin Oncol. 2007;25(18 Suppl):4510.
32. Schuhmacher C, Schlag P, Lordick F, Hohenberger W, Heise J, Haag C, et al. Neoadjuvant chemotherapy versus surgery alone for locally advanced adenocarcinoma of the stomach and cardia: randomized EORTC phase III trial #40954. J Clin Oncol. 2009;25(15 Suppl):4510.
33. Skoropad V, Berdov B, Zagrebin V. Concentrated preoperative radiotherapy for resectable gastric cancer: 20-years follow-up of a randomized trial. J Surg Oncol. 2002;80(2):72-8. (Pubitemid 34569172)
34. Hu J-K, Chen Z-X, Zhou Z-G, Zhang B, Tian J, Chen J-P, et al. Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials. World J Gastroenterol. 2002;8(6):1023-8. (Pubitemid 35446414)
35. Janunger K-G, Hafstrom L, Glimelius B. Chemotherapy in gastric cancer: a review and updated meta-analysis. Eur J Surg. 2002;168(11):597-608. (Pubitemid 36355892)
36. Panzini I, Gianni L, Fattori PP, Tassinari D, Imola M, Fabbri P, et al. Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori. 2002;88(1):21-7. (Pubitemid 34269794)
37. Hu J-K, Li C-M, Chen X-Z, Chen Z-X, Zhou Z-G, Zhang B, et al. The effectiveness of intravenous 5-fluorouracil-containing chemotherapy after curative resection for gastric carcinoma: a systematic review of published randomized controlled trials. J Chemother. 2007;19(4):359-75.
38. Zhao S-L, Fang J-Y. The role of postoperative adjuvant chemotherapy following curative resection for gastric cancer: a meta-analysis. Cancer Invest. 2008;26(3):317-25. (Pubitemid 351329009)
39. Liu TS, Wang Y, Chen SY, Sun YH. An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer. Eur J Surg Oncol. 2008;34(11):1208-16.
40. Sun P, Xiang JB, Chen ZY. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg. 2009;96(1):26-33.
41. GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. J Am Med Assoc. 2010;303:1729-37.
42. Li H, Zhu F, Cao Y, Zhai L, Lin T. Meta-analyses of randomized trials assessing the effect of neoadjuvant chemotherapy in locally advanced gastric cancer. American Society of Clinical Oncology Annual Meeting. J Clin Oncol. 2010;28(Abstract):4042.
43. Ronellenfitsch U, Schwarzbach M, Hofheinz R, Kienle P, Hohenberger P, Jensen K, et al. Meta-analysis of preoperative chemotherapy (CTX) versus primary surgery for locoregionally advanced adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus (GE adenocarcinoma). J Clin Oncol. 2010;28(15 Suppl):4022.
44. Fiorica F, Cartei F, Enea M, Licata A, Cabibbo G, Carau B, et al. The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data. Cancer Treat Rev. 2007;33(8):729-40. (Pubitemid 350082668)
45. Valentini V, Cellini F, Minsky BD, Mattiucci GC, Balducci M, D'Agostino G, et al. Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. Radiother Oncol. 2009;92(2):176-83.
46. Lu JJ, Liu T, Leong C, Tey J, Zhang Z. Survival benefits from preoperative radiation therapy in gastric carcinoma: a meta-analysis. Int J Radiat Oncol Biol Phys. 2009;75 Suppl 1:2172;S258.
47. Hundahl SA, Macdonald JS, Benedetti J, Southwest Oncology Group, Gastric Intergoup. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol. 2002;9(3):278-86. (Pubitemid 34298633)
48. Macdonald JS, Benedetti J, Smalley S, Haller D, Hundahl S, Jessup J, et al. Chemoradiation of resected gastric cancer: a 10-year follow-up of the phase III trial INT0116 (SWOG 9008). J Clin Oncol. 2009;27(15 Suppl):4515.
49. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725-30.
50. Songun I, Keizer HJ, Hermans J, Klementschitsch P, de Vries JE, Wils JA, et al. Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG). Eur J Cancer. 1999;35(4):558-62. (Pubitemid 29192962)
51. Skoropad VY, Berdov BA, Mardynski YS, et al. A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery alone in resectable gastric carcinoma. Eur J Surg Oncol. 2000;26:773-9. (Pubitemid 32059836)
52. Shchepotin IB, Evan SRT, Chorny V, et al. Intensive preoperative radiotherapy with local hypothermia for the treatment of gastric carcinoma. Surg Oncol. 1994;3:37-44. (Pubitemid 24171939)
53. Zhang ZX, Gu XZ, Yin WB, et al. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC) - report on 370 patients. Int J Radiat Oncol Biol Phys. 1998;42:929-34. (Pubitemid 29004131)
54. Lordick F, Siewert JR. Recent advances in multimodal treatment for gastric cancer: a review. Gastric Cancer. 2005;8(2):78-85. (Pubitemid 40655516)
55. Dikken JL, Jansen EPM, Cats A, Bakker B, Hartgrink HH, Meershoek-Klein Kranenbarg E, et al. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol. 2010;26(15 Suppl):9654.
56. Kim S, Lim DH, Lee J, Kang WK, MacDonald JS, Park CH, et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys. 2005;63(5):1279-85. (Pubitemid 41628018)
57. Tepper JE, Gunderson LL. Radiation treatment parameters in the adjuvant postoperative therapy of gastric cancer. Semin Radiat Oncol. 2002;12(2):187-95. (Pubitemid 34522355)
58. Matzinger O, Gerber E, Bernstein Z, Maingon P, Haustermans K, Bosset JF, et al. EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach. Radiother Oncol. 2009;92(2):164-75.
59. Zhao K-L, Liao Z, Bucci MK, Komaki R, Cox JD, Yu ZH, et al. Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction. Radiother Oncol. 2007;84(3):283-9. (Pubitemid 47371159)
60. Watanabe M, Isobe K, Takisima H, Uno T, Ueno N, Kawakami H, et al. Intrafractional gastric motion and interfractional stomach deformity during radiation therapy. Radiother Oncol. 2008;87(3):425-31.
61. Alani S, Soyfer V, Strauss N, Schifter D, Corn BW. Limited advantages of intensity-modulated radiotherapy over 3D conformal radiation therapy in the adjuvant management of gastric cancer. Int J Radiat Oncol Biol Phys. 2009;74(2):562-6.
62. van der Geld YG, Senan S, van Sornsen de Koste JR, Verbakel WFAR, Slotman BJ, Lagerwaard FJ. A four-dimensional CT-based evaluation of techniques for gastric irradiation. Int J Radiat Oncol Biol Phys. 2007;69(3):903-9. (Pubitemid 47418419)